S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
The House votes for possible TikTok ban in the US, but don't expect the app to go away anytime soon
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
New York lawmakers pass $237 billion budget with policies to jump-start housing market
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
The House votes for possible TikTok ban in the US, but don't expect the app to go away anytime soon
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
New York lawmakers pass $237 billion budget with policies to jump-start housing market
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
The House votes for possible TikTok ban in the US, but don't expect the app to go away anytime soon
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
New York lawmakers pass $237 billion budget with policies to jump-start housing market
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
The House votes for possible TikTok ban in the US, but don't expect the app to go away anytime soon
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
New York lawmakers pass $237 billion budget with policies to jump-start housing market
NASDAQ:AVGR

Avinger (AVGR) Stock Price, News & Analysis

$3.93
+0.01 (+0.26%)
(As of 04/19/2024 ET)
Today's Range
$3.92
$4.05
50-Day Range
$2.82
$5.34
52-Week Range
$2.50
$18.00
Volume
5,572 shs
Average Volume
18,487 shs
Market Capitalization
$6.25 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.00

Avinger MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
27.2% Upside
$5.00 Price Target
Short Interest
Healthy
3.64% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($2.08) to ($1.35) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.01 out of 5 stars

AVGR stock logo

About Avinger Stock (NASDAQ:AVGR)

Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. Its lumivascular products comprise Lightbox imaging consoles; the Ocelot and Tigereye family of devices, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. The company is also developing IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. The company was incorporated in 2007 and is based in Redwood City, California.

AVGR Stock Price History

AVGR Stock News Headlines

Avinger (NASDAQ:AVGR) Now Covered by Analysts at StockNews.com
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
Avinger, Inc.
Shanetia S. Avinger
Avinger, Inc.: Avinger Reports Third Quarter 2023 Results
Avinger Reports Third Quarter 2023 Results
Avinger (AVGR) Reports Q3 Loss, Lags Revenue Estimates
Avinger Earnings Preview
Avinger Raises $5.3 Million via At-The-Market Facility
See More Headlines
Receive AVGR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avinger and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/20/2024
Today
4/20/2024
Next Earnings (Estimated)
5/08/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:AVGR
Employees
68
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$5.00
High Stock Price Target
$5.00
Low Stock Price Target
$5.00
Potential Upside/Downside
+27.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-18,320,000.00
Net Margins
-239.41%
Pretax Margin
-239.41%

Debt

Sales & Book Value

Annual Sales
$7.65 million
Book Value
($4.53) per share

Miscellaneous

Free Float
1,518,000
Market Cap
$6.25 million
Optionable
Not Optionable
Beta
1.26
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

  • Mr. Jeffrey M. Soinski (Age 62)
    President, CEO & Director
    Comp: $616.79k
  • Mr. Nabeel P. Subainati (Age 40)
    VP of Finance, Principal Financial Officer & Accounting Officer
    Comp: $347.58k
  • Mr. Himanshu N. Patel (Age 64)
    Chief Technology Officer
    Comp: $430.08k
  • Mr. Keith Schaefer
    Chief Operating Officer
  • Mr. Philip R. Preuss (Age 46)
    Chief Marketing Officer & VP of Business Operations
  • Mr. Corey Gibbs
    Vice President of Sales
  • Dr. Jaafer Golzar FACC
    M.D., Chief Medical Officer

AVGR Stock Analysis - Frequently Asked Questions

Should I buy or sell Avinger stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Avinger in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" AVGR shares.
View AVGR analyst ratings
or view top-rated stocks.

What is Avinger's stock price target for 2024?

1 brokerages have issued 1 year target prices for Avinger's stock. Their AVGR share price targets range from $5.00 to $5.00. On average, they expect the company's stock price to reach $5.00 in the next year. This suggests a possible upside of 27.2% from the stock's current price.
View analysts price targets for AVGR
or view top-rated stocks among Wall Street analysts.

How have AVGR shares performed in 2024?

Avinger's stock was trading at $2.71 at the beginning of the year. Since then, AVGR shares have increased by 45.0% and is now trading at $3.93.
View the best growth stocks for 2024 here
.

Are investors shorting Avinger?

Avinger saw a drop in short interest in the month of March. As of March 31st, there was short interest totaling 50,300 shares, a drop of 43.9% from the March 15th total of 89,600 shares. Based on an average daily trading volume, of 52,900 shares, the days-to-cover ratio is currently 1.0 days. Currently, 3.6% of the company's stock are short sold.
View Avinger's Short Interest
.

When is Avinger's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024.
View our AVGR earnings forecast
.

How were Avinger's earnings last quarter?

Avinger, Inc. (NASDAQ:AVGR) released its earnings results on Wednesday, March, 20th. The medical device company reported ($3.93) EPS for the quarter, missing analysts' consensus estimates of $0.64 by $4.57. The medical device company had revenue of $1.91 million for the quarter, compared to analysts' expectations of $2.52 million.

When did Avinger's stock split?

Shares of Avinger reverse split on Wednesday, September 13th 2023. The 1-15 reverse split was announced on Wednesday, September 13th 2023. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, September 13th 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

What other stocks do shareholders of Avinger own?
When did Avinger IPO?

Avinger (AVGR) raised $60 million in an initial public offering (IPO) on Friday, January 30th 2015. The company issued 4,600,000 shares at a price of $12.00-$14.00 per share. Canaccord Genuity and Cowen and Company acted as the underwriters for the IPO and Oppenheimer, BTIG and Stephens were co-managers.

How do I buy shares of Avinger?

Shares of AVGR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:AVGR) was last updated on 4/21/2024 by MarketBeat.com Staff

From Our Partners